To overcome the disadvantages of poor intrinsic conductivity and stability of ZnCoO, a ZnCoO@MnMoO composite as an emerging pseudocapacitor electrode material with high specific capacitance, environmental friendliness, morphological diversity, and unique hierarchical structure was synthesized a simple two-step hydrothermal method. The research results indicate that the ZnCoO@MnMoO composite can present a high specific capacity of 1628 F g at a current density of 1 A g and good cycling stability with 69% capacity retention after 10 000 cycles at 10 A g. Hybrid supercapacitors (HSCs) assembled with the ZnCoO@MnMoO cathode and activated carbon anode can deliver an energy density of 48 W h kg at a power density of 695 W kg, and their capacity retention reached 61% after 8000 charge-discharge cycles at a current density of 10 A g. This could be attributed to the synergistic effect of the specific surface area and electrical conductivity enhanced by compositing ZnCoO with MnMoO. As a result, the excellent electrochemical properties show that the ZnCoO@MnMoO composite has strong application potential for high-performance supercapacitors.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1039/d4dt01896f | DOI Listing |
Biochem Biophys Res Commun
January 2025
Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Khalid University, Abha, Saudi Arabia. Electronic address:
Objective And Significance: Transforming growth factor-beta (TGF-β) plays a pivotal role in breast development by modulating tissue composition during the developmental phase. The TGFβ type II receptor (TGFβ RII) is implicated in breast cancer and represents a valuable therapeutic target. Due to the off-target side effects of many existing TGFβI/TGFβ RII inhibitors, a more targeted approach to drug discovery is necessary.
View Article and Find Full Text PDFAnn Intern Med
January 2025
Department of Pharmacoepidemiology, Graduate School of Medicine and Public Health, Kyoto University, Kyoto, Japan (K.K.).
Background: Dialysis patients have high rates of fracture morbidity, but evidence on optimal management strategies for osteoporosis is scarce.
Objective: To determine the risk for cardiovascular events and fracture prevention effects with denosumab compared with oral bisphosphonates in dialysis-dependent patients.
Design: An observational study that attempts to emulate a target trial.
Ann Intern Med
January 2025
University of Liverpool, Liverpool, United Kingdom (S.H.L., G.Y.L.).
GIM/FP/GP: [Formula: see text] Cardiology: [Formula: see text].
View Article and Find Full Text PDFAnn Intern Med
January 2025
University Hospital La Paz, Madrid, Spain (R.M.).
GIM/FP/GP: [Formula: see text] Cardiology: [Formula: see text].
View Article and Find Full Text PDFAnn Intern Med
January 2025
Washington University School of Medicine, St. Louis, Missouri, USA (M.W.R.).
GIM/FP/GP: [Formula: see text] Cardiology: [Formula: see text] Geriatrics: [Formula: see text].
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!